SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-000862
Filing Date
2024-02-07
Accepted
2024-02-07 16:31:56
Documents
85
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20231231x10q.htm   iXBRL 10-Q 2442168
2 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 9642
3 EX-31.2 tmb-20231231xex31d2.htm EX-31.2 9632
4 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 5725
5 EX-32.2 tmb-20231231xex32d2.htm EX-32.2 5751
  Complete submission text file 0001558370-24-000862.txt   12268968

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20231231.xsd EX-101.SCH 53556
7 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 87055
8 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 237702
9 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 504411
10 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 437656
87 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10q_htm.xml XML 3214542
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17272 | Film No.: 24604770
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)